FDA Reopens Comment Period for Proposed Rule on Prescription Drug Labels

Summary

The FDA is extending the comment period for a proposed rule on labeling requirements for human prescription drugs and biologics until June 22, 2001, in response to a request from pharmaceutical manufacturers, allowing more time for public input on the proposed rule.